These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29217413)

  • 1. Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk: A community-based cohort study.
    Qi Y; Liu J; Wang W; Wang M; Zhao F; Sun J; Liu J; Zhao D
    J Clin Lipidol; 2018; 12(1):89-98.e2. PubMed ID: 29217413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between apolipoprotein E-containing HDL-C and coronary heart disease risk: a community-based cohort study].
    Qi Y; Liu J; Wang M; Sun JY; Liu J; Deng QJ; Zhao D
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Feb; 42(2):297-302. PubMed ID: 33626619
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: a community-based cohort study.
    Qi Y; Fan J; Liu J; Wang W; Wang M; Sun J; Liu J; Xie W; Zhao F; Li Y; Zhao D
    J Am Coll Cardiol; 2015 Feb; 65(4):355-363. PubMed ID: 25634834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk.
    Morton AM; Koch M; Mendivil CO; Furtado JD; Tjønneland A; Overvad K; Wang L; Jensen MK; Sacks FM
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein.
    Corsetti JP; Gansevoort RT; Bakker SJ; Navis G; Sparks CE; Dullaart RP
    Metabolism; 2012 Jul; 61(7):996-1002. PubMed ID: 22225956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies.
    Joshi PH; Toth PP; Lirette ST; Griswold ME; Massaro JM; Martin SS; Blaha MJ; Kulkarni KR; Khokhar AA; Correa A; D'Agustino RB; Jones SR;
    Eur J Prev Cardiol; 2016 Jan; 23(1):41-9. PubMed ID: 25062744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
    Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
    Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts.
    Jensen MK; Aroner SA; Mukamal KJ; Furtado JD; Post WS; Tsai MY; Tjønneland A; Polak JF; Rimm EB; Overvad K; McClelland RL; Sacks FM
    Circulation; 2018 Mar; 137(13):1364-1373. PubMed ID: 29162611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
    Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
    Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
    Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.
    Sacks FM; Liang L; Furtado JD; Cai T; Davidson WS; He Z; McClelland RL; Rimm EB; Jensen MK
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2714-2727. PubMed ID: 32907368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia.
    Koch M; DeKosky ST; Goodman M; Sun J; Furtado JD; Fitzpatrick AL; Mackey RH; Cai T; Lopez OL; Kuller LH; Mukamal KJ; Jensen MK
    JAMA Netw Open; 2020 Jul; 3(7):e209250. PubMed ID: 32648923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of high-density lipoprotein and apolipoprotein E genetic variants with age-related macular degeneration.
    Cezario SM; Calastri MC; Oliveira CI; Carmo TS; Pinhel MA; Godoy MF; Jorge R; Cotrim CC; Souza DR; Siqueira RC
    Arq Bras Oftalmol; 2015; 78(2):85-8. PubMed ID: 25945528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease.
    Talayero B; Wang L; Furtado J; Carey VJ; Bray GA; Sacks FM
    J Lipid Res; 2014 Oct; 55(10):2167-77. PubMed ID: 24966274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study.
    Lamprea-Montealegre JA; Sharrett AR; Matsushita K; Selvin E; Szklo M; Astor BC
    Atherosclerosis; 2014 May; 234(1):42-6. PubMed ID: 24607852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein cholesterol, apolipoprotein E and atherogenic index of plasma are associated with risk of chronic kidney disease.
    Smajić J; Hasić S; Rašić S
    Med Glas (Zenica); 2018 Aug; 15(2):115-121. PubMed ID: 30047539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in apolipoprotein E-containing high-density lipoprotein (HDL) have little impact on HDL-cholesterol measurements using homogeneous assays in normolipidemic and dyslipidemic subjects.
    Sasamoto K; Hirayama S; Kon M; Seino U; Ueno T; Nagao Y; Hirayama A; Isshiki M; Idei M; Yano K; Miida T
    Clin Chim Acta; 2017 Jul; 470():56-63. PubMed ID: 28442245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.